AXA Framlington Biotech R Acc NAV

IMA Sector:

Specialist

ISIN:

GB0031007254

Fund Type:

Unit Trust

253.70p
   
  • PEP:
  • ISA:
  • CAT Std:
  • Date: 20-Aug-2025
  • Change: -1.50p
  • Change %: -0.59%
  • Currency: GBP
  • YTD change: -11.00p
  • YTD %: -4.16%

Holdings Breakdown

Holding Chart
Key % Net Assets
CELGENE CORP 7.1%
AMGEN INC 7.1%
ALEXION PHARMACEUTICALS INC 6.7%
VERTEX PHARMACEUTICAL 5.4%
Other 73.7%

Top 10 Holdings

Name % Net Assets
CELGENE CORP 7.1%
AMGEN INC 7.1%
ALEXION PHARMACEUTICALS INC 6.7%
VERTEX PHARMACEUTICAL 5.4%
TEVA PHARMACEUTICAL INDUSTRIES 4.9%
PHARMASSET INC 4.5%
SHIRE PLC 4.4%
ILLUMINA INC 4.2%
REGENERON PHARMACEUTICALS INC 4.0%
GILEAD SCIENCES INC 3.8%

Asset Allocation

No asset data available.

 

Price Info

Date 20-Aug-2025
NAV 253.70p
Currency GBP
Change -1.50p
% -0.59%
YTD change -11.00p
YTD % -4.16%

Fund Facts

Fund Inception 31/12/2001
Fund Manager ANDY SMITH
TER 1.90 (31-Aug-2011)

Fund Reports

Minimum Investment
Initial £1000
Additional £100
Savings £50
Charges
Initial 5.50%
Annual Mang't 1.75%
Exit n/a

Risks

Name %
Standard deviation 0.03
Sharpe ratio -0.10

Top of Page